Milad Torabfam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Milad Torabfam has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Meral Yüce
SUNUM Nanotechnology Research and Application Centre, Sabanci University, Istanbul 34956, Türkiye
5 shared publications Hasan Kurt
Istanbul Medipol University, School of Engineering and Natural Sciences, Istanbul, 34810, Turkey
3 shared publications- Mustafa Kemal Bayazit
Sabanci University Nanotechnology Research and Application Center SUNUM Universite Caddesi, Tuzla Istanbul Turkey
3 shared publications - Ayhan Parlar
Sabanci University, Faculty of Engineering and Natural Sciences, 34956, Istanbul, Turkey
2 shared publications - Busra Gurel
SUNUM Nanotechnology Research and Application Center, Sabanci University, Istanbul 34956, Turkey
2 shared publications - Omowunmi A. Sadik
BioSensor Materials for Advanced Research and Technology (The BioSMART Center), Chemistry and Environmental Science Department, New Jersey Institute of Technology, University Heights, 161 Warren Street, Newark, New Jersey 07102, United States
2 shared publications
Latest Publications
- Open Access
Discovery of a novel dehalogenase from Achromobacter mucicolens for PFAS defluorination
Here, we report the purification and characterization of a haloacid dehalogenase type II (HAD-II) enzyme capable of direct and cell-free enzymatic defluorination by cleaving the resilient C-F bond in perfluorooctanoic acid (PFOA). While conventional remediation strategies rely on energy-intensive chemical/thermal methods, biological alternatives are limited by long whole-microbiome incubations and poorly understood metabolic pathways. We discovered a novel HAD-II enzyme from Achromobacter mucicolens found in PFAS-contaminated lacustrine sediment, providing evidence of real-time microbial adaptation. Within 24-hour incubation, the system released approximately 0.55 ppm fluoride (17% yield) from a 5ppm PFOA (equivalent to maximum fluoride of 3.24 ppm) in recombinant enzyme assays. Structural and phylogenetic analyses reveal that the newly discovered HAD-II belongs to a deeply divergent lineage sharing only 25% sequence identity with the previously characterized Delftia homologue while preserving the core HAD-like catalytic fold. Comparative molecular docking further elucidated this functional divergence, demonstrating that PFOA adopts a productive binding orientation near the conserved catalytic Asp15 within the A. mucicolens active-site pocket, whereas the Delftia counterpart forces non-productive binding outside the catalytic site. Together, our work unveils a previously unrecognized Achromobacter -associated dehalogenase that mediates PFAS defluorination despite severe sequence divergence, offering a critical new paradigm for targeted biological remediation.
Open AccessDiscovery of a novel dehalogenase from Achromobacter mucicolens for PFAS defluorination
Here, we report the purification and characterization of a haloacid dehalogenase type II (HAD-II) enzyme capable of direct and cell-free enzymatic defluorination by cleaving the resilient C-F bond in perfluorooctanoic acid (PFOA). While conventional remediation strategies rely on energy-intensive chemical/thermal methods, biological alternatives are limited by long whole-microbiome incubations and poorly understood metabolic pathways. We discovered a novel HAD-II enzyme from Achromobacter mucicolens found in PFAS-contaminated lacustrine sediment, providing evidence of real-time microbial adaptation. Within 24-hour incubation, the system released approximately 0.55 ppm fluoride (17% yield) from a 5ppm PFOA (equivalent to maximum fluoride of 3.24 ppm) in recombinant enzyme assays. Structural and phylogenetic analyses reveal that the newly discovered HAD-II belongs to a deeply divergent lineage sharing only 25% sequence identity with the previously characterized Delftia homologue while preserving the core HAD-like catalytic fold. Comparative molecular docking further elucidated this functional divergence, demonstrating that PFOA adopts a productive binding orientation near the conserved catalytic Asp15 within the A. mucicolens active-site pocket, whereas the Delftia counterpart forces non-productive binding outside the catalytic site. Together, our work unveils a previously unrecognized Achromobacter -associated dehalogenase that mediates PFAS defluorination despite severe sequence divergence, offering a critical new paradigm for targeted biological remediation.
- 11 February 2025
- Published by American Chemical Society (ACS) in ACS ES&T Water
- Vol. 5 (3) , 1158-1172
Scalable Electrochemical Detection and Degradation of 1,4-Dioxane in Water and Wastewater: A Core–Shell Bimetallic Nanocatalyst and Simulation Study
- 11 February 2025
- Published by American Chemical Society (ACS) in ACS ES&T Water
- Vol. 5 (3) , 1158-1172
Scalable Electrochemical Detection and Degradation of 1,4-Dioxane in Water and Wastewater: A Core–Shell Bimetallic Nanocatalyst and Simulation Study
- 19 May 2022
- Published by Royal Society of Chemistry (RSC) in Reaction Chemistry & Engineering
- Vol. 7 (7) , 1510-1524
Microwave-promoted continuous flow synthesis of thermoplastic polyurethane–silver nanocomposites and their antimicrobial performance
Thermoplastic polyurethane–silver nanocomposites (PU–Ag NCs) have considerable potential in many medical applications due to their superior mechanical and antimicrobial properties. Herein, a microwave-promoted flow system is successfully employed for continuous in situ manufacturing of PU NCs having spherical silver nanoparticles (AgNPs) without any reducing agent at ∼40 °C in approximately 4 minutes. The main experimental parameters, including microwave power, metal salt concentration, polymer concentration, and flow rate, are optimised for the reproducible synthesis of AgNPs (∼5 nm) in the PU matrix, characterised by HRTEM-EDS and DLS analysis. XRD patterns indicate an increase in PU crystallinity with decreased particle size. Conventional heating flow synthesis at ∼50 °C or microwave-batch synthesis (MWB) at ∼44 and ∼50 °C is ineffective in preparing AgNPs, and only large AgNPs (>100 nm) are synthesised at 70 °C in the MWB reactor. PU–Ag NC films bearing small AgNPs (∼5 nm) exhibit superior antibacterial activity (>97%) against Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus compared to large NPs (∼218 nm). The proposed method may manufacture other metal–polymer matrix composites.
- 19 May 2022
- Published by Royal Society of Chemistry (RSC) in Reaction Chemistry & Engineering
- Vol. 7 (7) , 1510-1524
Microwave-promoted continuous flow synthesis of thermoplastic polyurethane–silver nanocomposites and their antimicrobial performance
Thermoplastic polyurethane–silver nanocomposites (PU–Ag NCs) have considerable potential in many medical applications due to their superior mechanical and antimicrobial properties. Herein, a microwave-promoted flow system is successfully employed for continuous in situ manufacturing of PU NCs having spherical silver nanoparticles (AgNPs) without any reducing agent at ∼40 °C in approximately 4 minutes. The main experimental parameters, including microwave power, metal salt concentration, polymer concentration, and flow rate, are optimised for the reproducible synthesis of AgNPs (∼5 nm) in the PU matrix, characterised by HRTEM-EDS and DLS analysis. XRD patterns indicate an increase in PU crystallinity with decreased particle size. Conventional heating flow synthesis at ∼50 °C or microwave-batch synthesis (MWB) at ∼44 and ∼50 °C is ineffective in preparing AgNPs, and only large AgNPs (>100 nm) are synthesised at 70 °C in the MWB reactor. PU–Ag NC films bearing small AgNPs (∼5 nm) exhibit superior antibacterial activity (>97%) against Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus compared to large NPs (∼218 nm). The proposed method may manufacture other metal–polymer matrix composites.
- Open Access
- 9 May 2022
- Published by Royal Society of Chemistry (RSC) in Sensors & Diagnostics
- Vol. 1 (4) , 765-774
Plasmonic nanometal surface energy transfer-based dual excitation biosensing of pathogens
NSET-based multiplex biosensor was demonstrated. The NSET pairs of UCNP/Au nanourchins and QD/Au nanorods ensured a highly sensitive, facile, and simultaneous screen of foodborne bacterial pathogens, S. typhimurium and E. coli, in a single pot.
- 9 May 2022
- Published by Royal Society of Chemistry (RSC) in Sensors & Diagnostics
- Vol. 1 (4) , 765-774
Open AccessPlasmonic nanometal surface energy transfer-based dual excitation biosensing of pathogens
NSET-based multiplex biosensor was demonstrated. The NSET pairs of UCNP/Au nanourchins and QD/Au nanorods ensured a highly sensitive, facile, and simultaneous screen of foodborne bacterial pathogens, S. typhimurium and E. coli, in a single pot.
- 4 March 2022
- Published by Royal Society of Chemistry (RSC) in Green Chemistry
- Vol. 24 (7) , 2812-2824
A microwave-powered continuous fluidic system for polymer nanocomposite manufacturing: a proof-of-concept study
Continuous manufacturing of pure nanocrystals with a narrow size distribution in a polymer matrix is very challenging, although it is highly crucial to get their full potential for advanced applications. A long-lasting nanocomposite (NC) manufacturing challenge is, for the first time, overcome by a microwave-powered fluidic system (MWFS). The effect of microwave power (MWP), flow rate, and the concentration of the reagents are systematically studied. The nylon-6 NC bearing evenly distributed silver nanoparticles (AgNPs) with a mean size of ∼2.59 ± 0.639 nm is manufactured continuously in ∼2 min at ∼50–55 °C using a green solvent, formic acid. The AgNP size becomes smaller when increasing the polymer concentration gradually. Small NPs with a narrow size distribution are produced at high MWP (40 W), but large ones with a broad size distribution at low MWP (10 W). The nylon-6 crystallinity is NP size-dependent, and the γ-phase (pseudo-hexagonal crystal) is dominant in the presence of small NPs as against the large counterparts. Given the small-sized AgNPs in the MWF-manufactured NCs, the antibacterial activity tests with Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa show superior activity compared to that of the large AgNP-bearing (∼50 nm) NCs produced in a conventional heating fluidic system. The proposed MWFS can manufacture other added-value NCs continuously.
- 4 March 2022
- Published by Royal Society of Chemistry (RSC) in Green Chemistry
- Vol. 24 (7) , 2812-2824
A microwave-powered continuous fluidic system for polymer nanocomposite manufacturing: a proof-of-concept study
Continuous manufacturing of pure nanocrystals with a narrow size distribution in a polymer matrix is very challenging, although it is highly crucial to get their full potential for advanced applications. A long-lasting nanocomposite (NC) manufacturing challenge is, for the first time, overcome by a microwave-powered fluidic system (MWFS). The effect of microwave power (MWP), flow rate, and the concentration of the reagents are systematically studied. The nylon-6 NC bearing evenly distributed silver nanoparticles (AgNPs) with a mean size of ∼2.59 ± 0.639 nm is manufactured continuously in ∼2 min at ∼50–55 °C using a green solvent, formic acid. The AgNP size becomes smaller when increasing the polymer concentration gradually. Small NPs with a narrow size distribution are produced at high MWP (40 W), but large ones with a broad size distribution at low MWP (10 W). The nylon-6 crystallinity is NP size-dependent, and the γ-phase (pseudo-hexagonal crystal) is dominant in the presence of small NPs as against the large counterparts. Given the small-sized AgNPs in the MWF-manufactured NCs, the antibacterial activity tests with Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa show superior activity compared to that of the large AgNP-bearing (∼50 nm) NCs produced in a conventional heating fluidic system. The proposed MWFS can manufacture other added-value NCs continuously.
- 8 October 2021
- Published by Taylor & Francis
- p. 131-146
Characterization of Biological Molecule—Loaded Nanostructures Using Circular Dichroism and Fourier Transform Infrared Spectroscopy
Drug-loaded nanoparticles have many advantages in drug administration, which is an essential step for the impact of the drugs 132and their mechanism of action. The predominant administration methods are oral and injection, which leads to the circulation of the drug in the whole body and the dysfunction of some tissue and organs because of the side effects. The efficacy of conventional drugs is low because only a small amount of the dose reaches the target site. Therefore a substantial amount of the drug is needed to sustain bioavailability. Nanoparticle-based drugs minimize these side effects and diminish the required drug amount. Unique physicochemical properties of nanoparticles, including an ultrasmall size (<1000 nm), high surface-to-volume ratio, and stability, provide significant advantages for delivering different drug molecules or biologically active substances (antibody, DNA, RNA) to targeted cells, tissues, and biological membranes of interest [1]. Encapsulation or conjugation by nanoparticles increases the therapeutic efficacy of the medications by protecting them from chemical and enzymatic degradation. Some of the critical physicochemical properties of nanoparticles regarding the therapeutic efficacy are size, shape and surface charges, particle roughness, stability, aggregation states, purity, and reactivity [2]. Although nanoparticle-based drugs with reduced side effects compared to chemical medicines will bring many advances over the current diagnosis and treatment technologies, these systems themselves have potential risks for the patients. Therefore, physicochemical properties and biological functions of functional nanoparticles must be characterized by state-of-the-art tools in advance [3]. Among various characterization methods, circular dichroism (CD) provides data for the secondary structure change of biological molecules after they are loaded onto nanoparticles, since most of the biotechnological products are optically active and chiral in structure. Fourier transform infrared (FTIR) spectroscopy, on the other hand, is a fundamental method to investigate chemical bonds before and after nanoparticle conjugation. This chapter focuses on these two critical techniques that are employed in the characterization of biological molecule–loaded nanoparticle conjugates. The section provides the audience with the basic principles and operating procedures of CD and FTIR technologies, followed by specific examples from the recent literature.
- 8 October 2021
- Published by Taylor & Francis
- p. 131-146
Characterization of Biological Molecule—Loaded Nanostructures Using Circular Dichroism and Fourier Transform Infrared Spectroscopy
Drug-loaded nanoparticles have many advantages in drug administration, which is an essential step for the impact of the drugs 132and their mechanism of action. The predominant administration methods are oral and injection, which leads to the circulation of the drug in the whole body and the dysfunction of some tissue and organs because of the side effects. The efficacy of conventional drugs is low because only a small amount of the dose reaches the target site. Therefore a substantial amount of the drug is needed to sustain bioavailability. Nanoparticle-based drugs minimize these side effects and diminish the required drug amount. Unique physicochemical properties of nanoparticles, including an ultrasmall size (<1000 nm), high surface-to-volume ratio, and stability, provide significant advantages for delivering different drug molecules or biologically active substances (antibody, DNA, RNA) to targeted cells, tissues, and biological membranes of interest [1]. Encapsulation or conjugation by nanoparticles increases the therapeutic efficacy of the medications by protecting them from chemical and enzymatic degradation. Some of the critical physicochemical properties of nanoparticles regarding the therapeutic efficacy are size, shape and surface charges, particle roughness, stability, aggregation states, purity, and reactivity [2]. Although nanoparticle-based drugs with reduced side effects compared to chemical medicines will bring many advances over the current diagnosis and treatment technologies, these systems themselves have potential risks for the patients. Therefore, physicochemical properties and biological functions of functional nanoparticles must be characterized by state-of-the-art tools in advance [3]. Among various characterization methods, circular dichroism (CD) provides data for the secondary structure change of biological molecules after they are loaded onto nanoparticles, since most of the biotechnological products are optically active and chiral in structure. Fourier transform infrared (FTIR) spectroscopy, on the other hand, is a fundamental method to investigate chemical bonds before and after nanoparticle conjugation. This chapter focuses on these two critical techniques that are employed in the characterization of biological molecule–loaded nanoparticle conjugates. The section provides the audience with the basic principles and operating procedures of CD and FTIR technologies, followed by specific examples from the recent literature.
- 1 April 2021
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1152, 238189
Fractionated charge variants of biosimilars: A review of separation methods, structural and functional analysis
- 1 April 2021
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1152, 238189
Fractionated charge variants of biosimilars: A review of separation methods, structural and functional analysis